LENZ Sale Disclosure
Ra Capital Management, L.p. · SEC Form 4 · Filed Nov 2, 2026
Sale
Calculated transaction value
$1.52M
Ra Capital Management, L.p. 10% owner
LENZ
LENZ Therapeutics
LENZ
Transaction date
Oct 29, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 4 days later
LENZ daily price context
Close on/before transaction
$3.49
Oct 29, 2026
First close after public filing
$3.5
Nov 3, 2026
Return after filing · so far
0.0%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 451,998 shares @ $3.36
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001231919-26-001526
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$9.13M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lenz Therapeutics, Inc. LENZ Current | Sale | Oct 29, 2026 | $1.52M |
| Lenz Therapeutics, Inc. LENZ | Sale | Oct 29, 2026 | $360.09K |
| Lenz Therapeutics, Inc. LENZ | Sale | Oct 29, 2026 | $7.26M |